102997-01-3 Usage
Uses
Used in Pharmaceutical Industry:
5,6,7,8-TETRAHYDRO-4H-THIENO[2,3-D]AZEPINE is used as a reagent for the preparation of ethynylpyridines and related compounds. These compounds are known to act as melanin-concentrating hormone receptor (MCH-1) antagonists, which can be utilized in the treatment of metabolic disorders.
In the context of metabolic disorders, MCH-1 antagonists have the potential to regulate appetite and energy balance, making them a promising therapeutic option for conditions such as obesity and diabetes. By targeting the MCH-1 receptor, these antagonists can help modulate the body's metabolic processes and improve overall health.
Furthermore, the compound's role as a reagent in the synthesis of ethynylpyridines and related compounds highlights its importance in the development of novel pharmaceuticals. The unique structural features of 5,6,7,8-TETRAHYDRO-4H-THIENO[2,3-D]AZEPINE enable the creation of a wide range of bioactive molecules with potential applications in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 102997-01-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,9,9 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 102997-01:
(8*1)+(7*0)+(6*2)+(5*9)+(4*9)+(3*7)+(2*0)+(1*1)=123
123 % 10 = 3
So 102997-01-3 is a valid CAS Registry Number.
102997-01-3Relevant academic research and scientific papers
RESORCINOL DERIVATIVE AS HSP90 INHIBITOR
-
, (2017/12/27)
The present invention relates to a compound represented by formula (I) of a resorcinol derivative as an HSP90 inhibitor or pharmaceutically accepted salts thereof. The compound in the present invention has the activity of inhibiting heat shock protein HSP90. Therefore, the compound in the present invention is used to treat proliferative diseases such as cancer and neurodegenerative diseases. The present invention further provides the compounds and preparation methods for pharmaceutical compositions comprising the compounds, a method for treating diseases, and pharmaceutical compositions comprising the compounds.
Substituted azepine derivatives as serotonin receptor modulators
-
Page/Page column 15, (2010/02/15)
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
